GKOS
Glaukos Corporation
NYSE · USHealthcareMedical - Devices
$155.46-0.87%
Price as of Jul 20, 2026
GKOS profitability
Glaukos Corporation profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 78.1%
- EBITDA margin
- -26.1%
- EBIT margin
- -15.6%
- Net margin
- -34.3%
- Free cash flow margin
- -3.4%
Returns
- Return on equity
- -28.2%
- Return on assets
- -21.2%
- Return on invested capital
- -11.1%
- Asset turnover
- 0.62x
Cash efficiency
- Cash from operations
- -$8.8M
- Cash per share
- $4.71
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.